Lisanti Capital Growth, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 199 filers reported holding TRANSMEDICS GROUP INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$2,894,791
-56.2%
34,470
-60.5%
0.40%
-56.5%
Q1 2023$6,602,899
+3.7%
87,190
-15.5%
0.92%
+5.9%
Q4 2022$6,368,578
+47.9%
103,1850.0%0.87%
+51.0%
Q3 2022$4,307,000
+29.5%
103,185
-2.5%
0.58%
+27.4%
Q2 2022$3,327,000
+213.0%
105,780
+188.4%
0.45%
+30.6%
Q2 2019$1,063,00036,6800.35%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders